ANALYSIS-Wegovy launch in UK may underline Novo's need to get ahead of Lilly
11/9 07:10
Novo Nordisk's decision to launch its weight-loss drug Wegovy in Britain last week despite severe supply constraints may partly have been motivated by a desire to get ahead of rival Eli Lilly's own similar drug, industry sources said....